Передовая |
|
Pokrovsky V.V.
Human immunodeficiency virus infection in Russia: strategies for its control
|
6-12 |
Problem-solving articles |
|
Pokrovskaya А.V., Sokolova E.V., Pokrovsky V.V.
Features of the HIV case accounting system in the Russian Federation
|
13-18 |
Original investigations |
|
Ladnaia N.N., Kozyrina N.V., Babikhina K.A., Mikhailov A.V., Egorova N.V., Godlevskaya M.V., Semenchenko M.V., Zograbyan L.S., Pokrovsky V.V.
The impact of the COVID-19 infection epidemic on the provision of health care for people living with HIV
|
19-27 |
Kuimova U.A., Belyaeva V.V., Kozyrina N.V., Kulabukhova E.I., Goliusova M.D., Narkevich A.N.
Analysis of factors influencing the readiness for coronavirus vaccination: results of a survey of HIV-infected patients
|
28-33 |
Suvorova Z.K., Belyaeva V.V., Pokrovskaya A.V., Andreev A.V., Popova A.A., Pokrovsky V.V., Sedushkina M.A., Bertran E.E., Zakharenko V.V., Volkova N.R., Zhurkina A.A.
Assessment of awareness about HIV infection in people with no fixed abode
|
34-39 |
Popova A.A., Domonova E.A., Vinogradova N.A., Shipulina O.Yu.
Anogenital human papillomavirus infection in HIV-infected women (according to the results of a pilot study in the Moscow Region)
|
40-45 |
Yurin O.G., Ladnaia N.N., Kravchenko A.V., Sokolova E.V., Suvorova Z.K., Narsiya R.S., Pokrovsky V.V.
Antiretroviral therapy in Russia
|
46-52 |
Kirichenko A.A., Kireev D.E., Shlykova A.V., Lopatukhin A.E., Lapovok I.A., Saleeva D.V., Kravchenko A.V., Pokrovsky V.V.
HIV-1 drug resistance in patients with virological inefficiency on ART in Russia in 2013–2021
|
53-62 |
elyaeva V.V., Kozyrina N.V., Sokolova E.V., Semikova S.Yu., Galiullin N.I., Lebedeva E.P., Beshimov A.T., Khoraskina E.A., Narkevich A.N., Gavrilova O.V., Suvorova Z.K., Khokhlova O.N.
Analysis of risk factors for non-adherence to follow-up and treatment for HIV infection: assessment of readiness to follow specialists’ recommendations
|
63-68 |
Shakhgildyan V.I., Yadrikhinskaya M.S., Orlovsky A.A., Domonova E.A., Shipulina O.Yu., Tishkevich O.A., Ermak T.N., Yarovaya E.B.
Viral, but not-COVID pneumonia in patients with HIV infection
|
69-77 |
Zimina V.N., Kravchenko A.V., Kulabukhova E.I., Suvorova Z.K., Pokrovskaya А.V., Khokhlova О.N., Vinokurova O.O., Li E.A., Kadyrova A.A., Papoyan A.S., Oganisyan R.A., Kralko V.Ya., Klimuk D.A., Bekbolotov A.A., Abdrakhmanova E.D., Soliev A.A., A’zamova Sh.A., Volchenkov G.V., Zamkovaya T.N., Pokrovsky V.V.
Multidrug-resistant tuberculosis in patients with HIV infection in the CIS countries
|
78-83 |
Reviews and lectures |
|
Ermak T.N.
Cutaneous leishmaniasis in patients with HIV infection
|
84-89 |
Exchange of experience |
|
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Kanestri V.G., Deulina M.O., Goliusova M.D., Kulabukhova E.I., Kozyrina N.V., Yurin O.G.
Results of treatment with a 60-week Russian ART regimen in patients with HIV infection
|
90-95 |
Orlova-Morozova E.A., Pronin A.Yu.
The use of doravirine as part of antiretroviral therapy regimens in patients with resistance mutations
|
96-99 |
Obituary |
|
In memory of Lyudmila Pavlovna Zueva
|
100 |